Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA6 | P23280 | 4/20 | 0.46 |
| ▸ | CA9 | Q16790 | 4/20 | 0.46 |
| ▸ | CA4 | P22748 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29654186 | 1.00 | ACE2 (0.53) | ACE2TSHRTP53PKMCA12 | |
| SCHEMBL17058903 | 0.90 | ACE2 (0.53) | ACE2TSHRTP53PKMCA12 | |
| SCHEMBL17625007 | 0.88 | ACE2 (0.51) | ACE2TSHRTP53PKMCA12 | |
| SCHEMBL8984332 | 0.85 | ACE2 (0.49) | ACE2TSHRTP53PKMKDM4E | |
| SCHEMBL1408523 | 0.84 | KDM4E (0.50) | ACE2TSHRTP53PKMCA12 | |
| SCHEMBL10548309 | 0.84 | PKM (0.48) | ACE2TSHRPKML3MBTL1MAPT | |
| SCHEMBL8482490 | 0.83 | ACE2 (0.50) | ACE2TSHRTP53PKMCA12 | |
| SCHEMBL8534552 | 0.83 | CA12 (0.59) | ACE2TSHRTP53PKMCA12 | |
| SCHEMBL12018296 | 0.83 | CPT1B (0.45) | ACE2TSHRTP53PKMPTGS2 | |
| SCHEMBL4109854 | 0.83 | PKM (0.69) | ACE2TSHRTP53PKMCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4245830-B1 | LUBRICANT BASE OIL | KAO CORP (JP) | 2025-09-10 | — | — | EP | disclosed |
| US-12098341-B2 | Lubricant base oil | KAO CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| CN-118255663-A | Extraction method and application of 3, 4-dihydroxymethyl benzoate | 大理大学 | 2024-06-28 | — | — | CN | disclosed |
| CN-118255663-A | Extraction method and application of 3, 4-dihydroxymethyl benzoate | 大理大学 | 2024-06-28 | — | — | CN | disclosed |
| US-20230383208-A1 | LUBRICANT BASE OIL | KAO CORPORATION (JP) | 2023-11-30 | — | — | US | disclosed |
| EP-4245830-A1 | LUBRICANT BASE OIL | Kao Corporation (JP) | 2023-09-20 | — | — | EP | disclosed |
| EP-2565245-B1 | Moisture-proof material | NITTO DENKO CORP (JP) | 2018-07-25 | — | — | EP | disclosed |
| US-9963427-B2 | Dithiol mucolytic agents | PARION SCIENCES, INC. (US) | 2018-05-08 | — | — | US | disclosed |
| US-20170283429-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | Janssen Biopharma, Inc. | 2017-10-05 | — | — | US | disclosed |
| US-9724351-B2 | Compounds for the treatment of paramoxyvirus viral infections | ALIOS BIOPHARMA, INC. (US) | 2017-08-08 | — | — | US | disclosed |
| EP-2666836-A2 | Moisture-proof material | Nitto Denko Corporation (JP) | 2013-11-27 | — | — | EP | disclosed |
| EP-2565245-A2 | Moisture-proof material | NITTO DENKO CORPORATION (JP) | 2013-03-06 | — | — | EP | disclosed |
| US-20130052461-A1 | MOISTURE-PROOF MATERIAL | NITTO DENKO CORPORATION (JP) | 2013-02-28 | — | — | US | disclosed |
| US-20120308640-A1 | AMPHIPHILIC JANUS-DENDRIMERS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2012-12-06 | — | — | US | disclosed |
| WO-2011017500-A1 | AMPHIPHILIC JANUS-DENDRIMERS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2011-02-10 | — | — | WO | disclosed |
| CN-101146780-A | New 3-aryl-1,2-benzisoxazole compounds are heat shock protein 90 inhibitors, useful to treat solid or liquid cancer, preferably cancers resistant to cytotoxic agents | AVENTIS PHARMA SA (FR) | 2008-03-19 | — | — | CN | disclosed |
| EP-0714390-B1 | INDOLE DERIVATIVES AS 5-ALPHA-REDUCTASE-1-INHIBITORS | PFIZER LTD (GB) | 2000-01-12 | — | — | EP | disclosed |
| US-5912357-A | Indole derivatives as 5-α-reductase-1-inhibitors | PFIZER INC (US) | 1999-06-15 | — | — | US | disclosed |
| EP-0714390-A1 | INDOLE DERIVATIVES AS 5-ALPHA-REDUCTASE-1-INHIBITORS | Pfizer Limited (GB) | 1996-06-05 | — | — | EP | disclosed |
| WO-1995005375-A1 | INDOLE DERIVATIVES AS 5-ALPHA-REDUCTASE-1-INHIBITORS | PFIZER LIMITED (GB) | 1995-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120308640-A1 | AMPHIPHILIC JANUS-DENDRIMERS | OR10J3, H1-10, CXCR3 | ACE2 3215/4885TSHR 852/4885TP53 4016/4885 |
| US-20170283429-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | MAVS, SARS1, ZC3HAV1 | ACE2 117/4885TSHR 4424/4885TP53 3470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.